We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Lindsay Corp
LNN
$1.16B
| $860K | ﹤0.01% |
+9,747
| New | +$886K |
|
|
APC
1577
DELISTED
Anadarko Petroleum
APC
| $860K | ﹤0.01% |
16,041
-98,700
| -86% | -$4.85M |
|
|
SIR
1578
DELISTED
SELECT INCOME REIT
SIR
| $858K | ﹤0.01% |
+77,668
| New | +$848K |
|
|
TSC
1579
DELISTED
TriState Capital Holdings, Inc.
TSC
| $856K | ﹤0.01% |
37,200
-8,300
| -18% | -$193K |
|
|
DSPG
1580
DELISTED
DSP Group Inc
DSPG
| $856K | ﹤0.01% |
68,477
-300
| -0.4% | -$3.95K |
|
|
TA
1581
DELISTED
TravelCenters of America LLC
TA
| $854K | ﹤0.01% |
41,650
+11,120
| +36% | +$258K |
|
1582
Unitil
UTL
$1,000M
| $851K | ﹤0.01% |
18,662
-3,400
| -15% | -$171K |
|
1583
Itaú Unibanco
ITUB
$91.3B
| $848K | ﹤0.01% |
134,455
-1,464,485
| -92% | -$9.35M |
|
1584
Enterprise Financial Services Corp
EFSC
$2.41B
| $845K | ﹤0.01% |
18,713
-1,600
| -8% | -$70K |
|
|
NCOM
1585
DELISTED
National Commerce Corporation
NCOM
| $845K | ﹤0.01% |
21,000
-5,300
| -20% | -$219K |
|
|
UPL
1586
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $844K | ﹤0.01% |
93,200
-6,100
| -6% | -$53.3K |
|
1587
Patrick Industries
PATK
$2.8B
| $837K | ﹤0.01% |
18,075
-12,975
| -42% | -$533K |
|
1588
iShares Select U.S. REIT ETF
ICF
$2.12B
| $831K | ﹤0.01% |
+16,400
| New | +$834K |
|
1589
Ennis
EBF
$546M
| $830K | ﹤0.01% |
39,995
-56,562
| -59% | -$1.13M |
|
|
ENZ
1590
DELISTED
Enzo Biochem, Inc.
ENZ
| $827K | ﹤0.01% |
101,473
-41,385
| -29% | -$395K |
|
|
KED
1591
DELISTED
Kayne Anderson Energy
KED
| $826K | ﹤0.01% |
47,400
+7,700
| +19% | +$123K |
|
|
CVSA
1592
Covista Inc
CVSA
$3.94B
| $821K | ﹤0.01% |
19,528
-155,100
| -89% | -$6.08M |
|
1593
Myers Industries
MYE
$1.18B
| $821K | ﹤0.01% |
42,107
-10,400
| -20% | -$218K |
|
1594
Editas Medicine
EDIT
$399M
| $814K | ﹤0.01% |
+26,500
| New | +$667K |
|
1595
Compass Diversified
CODI
$755M
| $811K | ﹤0.01% |
47,872
-73,800
| -61% | -$1.27M |
|
|
AVEO
1596
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $811K | ﹤0.01% |
29,074
+19,834
| +215% | +$616K |
|
1597
Matsons
MATX
$6.37B
| $805K | ﹤0.01% |
26,970
+1,400
| +5% | +$39.5K |
|
|
RYZ
1598
Ryerson Holding Corp
RYZ
$1.6B
| $805K | ﹤0.01% |
77,406
-88,900
| -53% | -$829K |
|
|
CMRX
1599
DELISTED
Chimerix, Inc.
CMRX
| $804K | ﹤0.01% |
173,712
+98,612
| +131% | +$469K |
|
|
CIVI
1600
DELISTED
Civitas Resources
CIVI
| $803K | ﹤0.01% |
+29,100
| New | +$913K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.